Schedule of Provision For Income Taxes (Details) - USD ($) |
1 Months Ended | 3 Months Ended | 11 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|---|
Dec. 31, 2022 |
Dec. 31, 2022 |
Mar. 31, 2023 |
Mar. 31, 2022 |
Dec. 12, 2022 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|
| Reorganization, Chapter 11 [Line Items] | |||||||
| Financial Designation, Predecessor and Successor [Fixed List] | Successor | Successor | Successor | Predecessor | Predecessor | Successor | Predecessor |
| Deferred tax benefit: | |||||||
| Federal | $ (151,625) | ||||||
| State | (34,844) | ||||||
| Deferred tax benefit | (186,469) | ||||||
| Change in valuation allowance | (558,581) | ||||||
| Provision for income taxes | $ (745,050) | $ (1,047,051) | |||||
| Predecessor [Member] | |||||||
| Reorganization, Chapter 11 [Line Items] | |||||||
| Financial Designation, Predecessor and Successor [Fixed List] | Predecessor | Predecessor | Predecessor | ||||
| Deferred tax benefit: | |||||||
| Federal | $ (2,191,344) | $ (1,480,472) | |||||
| State | (482,283) | (763,612) | |||||
| Deferred tax benefit | (2,673,627) | (2,244,084) | |||||
| Change in valuation allowance | 2,673,627 | 2,244,084 | |||||
| Provision for income taxes | |||||||
| X | ||||||||||
- Definition Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of deferred federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Indicates designation of financial information when substantially all business or separately identifiable line of business transfers from one entity to another entity. Acceptable values are "Predecessor" and "Successor". Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|